Director Saloni News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director saloni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Saloni Today - Breaking & Trending Today

Thorne HealthTech (NASDAQ:THRN) Releases FY 2022 Earnings Guidance

Thorne HealthTech (NASDAQ:THRN – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $0.28-$0.30 for the period, compared to the consensus estimate of $0.31. The company issued revenue guidance of $240.00 million-$250.00 million, compared to the consensus revenue estimate of $249.14 million. Separately, Zacks Investment […] ....

United States , Thorne Healthtech , Salonis Varma , Northern Trust Corp , Securities Exchange Commission , Thorne Healthtech Inc , Zacks Investment Research , Charles Schwab Investment Management Inc , Cubist Systematic Strategies , Citadel Advisors , Get Rating , Director Saloni , Exchange Commission , Systematic Strategies , Street Group , Trust Corp , Charles Schwab Investment Management , Nasdaq Thrn ,

Thorne HealthTech (THRN) to Release Quarterly Earnings on Wednesday

Thorne HealthTech (NASDAQ:THRN – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 11th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Thorne HealthTech has set its FY 2022 guidance at EPS.Parties that are interested in registering for the company’s […] ....

United States , Thorne Healthtech , Salonis Varma , Northern Trust Corp , Geode Capital Management , Securities Exchange Commission , Thorne Healthtech Inc , Zacks Investment Research , Blackrock Inc , Renaissance Technologies , Thorne Healthtech Company Profile Get Rating , Squarepoint Ops , Get Rating , Director Saloni , Exchange Commission , Trust Corp , Healthtech Company Profile , Nasdaq Thrn ,

Thorne HealthTech, Inc. (NASDAQ:THRN) Director Saloni S. Varma Acquires 9,223 Shares

Thorne HealthTech, Inc. (NASDAQ:THRN – Get Rating) Director Saloni S. Varma bought 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average price of $6.01 per share, with a total value of $55,430.23. The acquisition was disclosed in a filing with the Securities […] ....

New York , United States , Thorne Healthtech , Salonis Varma , York State Common Retirement Fund , Securities Exchange Commission , Thorne Healthtech Inc , Zacks Investment Research , Nuveen Asset Management , Deutsche Bank , Thorne Healthtech Company Profile Get Rating , Wells Fargo Company , Brown Advisory Inc , Get Rating , Director Saloni , Exchange Commission , Asset Management , New York State Common Retirement Fund , Healthtech Company Profile , Nasdaq Thrn , Insider Trading , Nsider Trades ,